AMY HUBER: Open Payments
NPI 1437183563 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 68 payments from 16 companies in 2025. Trend: 2023 $1,127 · 2024 $1,647 · 2025 $1,365
Food & beverage: $1,213Education: $152
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 23 | $273 |
| Janssen Biotech, Inc. | 10 | $267 |
| ABBVIE INC. | 15 | $177 |
| LEO Pharma Inc. | 4 | $160 |
| GENZYME CORPORATION | 4 | $146 |
| PFIZER INC. | 1 | $94 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| UCB, Inc. | 1 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Amgen Inc. | 1 | $29 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, SKYRIZI, ANZUPGO, LITFULO, ADBRY, Bimzelx.
Industry payments across CO — which companies pay providers there.
